Magnesium alloy sheet and method for producing same
US-9222161-B2 · Dec 29, 2015 · US
US10246763B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10246763-B2 |
| Application number | US-201313975881-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 26, 2013 |
| Priority date | Aug 24, 2012 |
| Publication date | Apr 2, 2019 |
| Grant date | Apr 2, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medical implant and/or device, which includes a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed. The implant and/or device can include a biodegradable and cytocompatible magnesium-zinc-strontium (Mg—Zn—Sr) alloy having a weight percent composition of Zn and Sr as follows: 0.01≤Zn≤6 wt %, 0.01≤Sr≤3 wt %. A method for manufacturing an implant in the form of a biodegradable and cytocompatible magnesium-zinc-strontium alloy is disclosed, which includes melting the biodegradable and cytocompatible magnesium-zinc-strontium alloy in an inert environment and molding the biodegradable magnesium-zinc-strontium alloy in a semi-solid state.
Opening claim text (preview).
What is claimed is: 1. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy; and a weight percent of zinc being 4.0 to 6.0, a weight percent of strontium being 0.01 to 0.15, and a balance of the medical implant being magnesium. 2. The medical implant according to claim 1 , wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 3. The medical implant according to claim 2 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 4. The medical implant according to claim 1 , wherein the implant is composed of only the biodegradable magnesium-zinc-strontium alloy. 5. The medical implant according to claim 1 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant. 6. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy, wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of Zn and Sr as follows: 4.0≤Zn≤6.0 wt. %, 0.01≤Sr≤0.15 wt. %, and a balance of the medical implant being magnesium; and wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 7. The medical implant according claim 6 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 8. The medical implant according to claim 6 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant. 9. The medical implant according to claim 6 , wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of 95.85 wt. % Mg, 4 wt. % Zn, and 0.15 wt. % Sr. 10. The medical implant according to claim 6 , wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent composition of 94.5-95.85 wt. % Mg, 4 wt. % Zn, and 0.01-0.15 wt. % Sr. 11. A medical implant consisting of: a biodegradable and cytocompatible magnesium-zinc-strontium alloy, wherein the biodegradable and cytocompatible magnesium-zinc-strontium alloy has a weight percent of 91-95.84 wt. % Mg, 4.0-6.0 wt. % Zn, and 0.01-0.015 wt. % Sr. 12. The medical implant according to claim 11 , wherein the implant is an orthopedic, dental, plastic surgical or vascular implant. 13. The medical implant according claim 12 , wherein the orthopedic, dental, plastic surgical or vascular implant is a bone screw, a bone anchor, a tissue staple, a suture, a craniofacial, maxillofacial reconstruction plate, a fastener, a reconstructive dental implant, a medical fixation device, or an embolization material. 14. The medical implant according to claim 11 , comprising: a coating layer composed of the biodegradable magnesium-zinc-strontium alloy on a surface of the medical implant or device.
with zinc or cadmium as the next major constituent · CPC title
Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title
Extruding metal; Impact extrusion · CPC title
Other specific inorganic materials not covered by A61L27/303 - A61L27/32 · CPC title
Metals or alloys · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.